We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+34.77%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$1.54B
AUM Growth
-$138M
Cap. Flow
-$300M
Cap. Flow %
-19.47%
Top 10 Hldgs %
9.99%
Holding
2,498
New
653
Increased
404
Reduced
598
Closed
777

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$2.77M
2
CI icon
Cigna
CI
+$2.57M
3
META icon
Meta Platforms (Facebook)
META
+$2.48M
4
BIDU icon
Baidu
BIDU
+$2.2M
5
BHC icon
Bausch Health
BHC
+$2.09M

Sector Composition

Rank Sector Weight
1 Healthcare 4.98%
2 Technology 4.63%
3 Consumer Discretionary 3.8%
4 Industrials 1.77%
5 Financials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRSL
851
PUT
Brightstar Lottery PLC
BRSL
$1.93B
$349K 0.02%
23,300
-3,200
-12% -$45.6K
INSP icon
852
CALL
Inspire Medical Systems
INSP
$1.47B
$349K 0.02%
+4,700
New +$302K
QUAD icon
853
Quad
QUAD
$438M
$349K 0.02%
+74,779
New +$467K
NEWR
854
CALL
DELISTED
New Relic, Inc.
NEWR
$348K 0.02%
5,300
-35,500
-87% -$2.31M
AFI
855
DELISTED
Armstrong Flooring, Inc.
AFI
$348K 0.02%
+81,384
New +$398K
AWR icon
856
CALL
American States Water
AWR
$3.37B
$347K 0.02%
+4,000
New +$354K
LRN icon
857
Stride
LRN
$3.83B
$345K 0.02%
16,979
+14,285
+530% +$305K
RMT
858
Royce Micro-Cap Trust
RMT
$735M
$343K 0.02%
40,201
+9,740
+32% +$79.6K
BLUE
859
CALL
DELISTED
bluebird bio
BLUE
$342K 0.02%
301
-656
-69% -$713K
AMHCU
860
DELISTED
Amplitude Healthcare Acquisition Corporation Unit
AMHCU
$341K 0.02%
+33,873
New +$339K
CALX icon
861
CALL
Calix
CALX
$2.32B
$340K 0.02%
+42,500
New +$317K
VISN
862
PUT
Vistance Networks Inc
VISN
$2.67B
$339K 0.02%
23,900
-20,700
-46% -$268K
WDC icon
863
Western Digital
WDC
$172B
$339K 0.02%
+7,069
New +$295K
TGTX icon
864
TG Therapeutics
TGTX
$8.53B
$338K 0.02%
+30,400
New +$231K
BABA icon
865
Alibaba
BABA
$276B
$337K 0.02%
1,590
+990
+165% +$186K
VIVO
866
DELISTED
Meridian Bioscience Inc
VIVO
$337K 0.02%
+34,500
New +$324K
CVGW
867
CALL
DELISTED
Calavo Growers
CVGW
$335K 0.02%
+3,700
New +$331K
INFN
868
CALL
DELISTED
Infinera Corporation Common Stock
INFN
$334K 0.02%
42,100
+32,100
+321% +$197K
GBT
869
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$334K 0.02%
4,200
-43,800
-91% -$2.6M
CYTK icon
870
Cytokinetics
CYTK
$10.9B
$333K 0.02%
+31,450
New +$323K
ICE icon
871
CALL
Intercontinental Exchange
ICE
$84.1B
$333K 0.02%
3,600
-79,300
-96% -$7.36M
VRRM icon
872
PUT
Verra Mobility
VRRM
$636M
$333K 0.02%
+23,800
New +$342K
IMGN
873
DELISTED
Immunogen Inc
IMGN
$333K 0.02%
65,262
-31,378
-32% -$106K
OMC icon
874
CALL
Omnicom Group
OMC
$23.5B
$332K 0.02%
+4,100
New +$321K
YUM icon
875
PUT
Yum! Brands
YUM
$40.7B
$332K 0.02%
3,300
+1,800
+120% +$186K

Similar funds

Walleye Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Walleye Capital held 2,498 positions worth $1.54B, down 8.2% from $1.68B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Walleye Capital withdrew a net $300M in Q4 2019, closing 777 positions and reducing 598 holdings. Its most notable exit was Cigna, an estimated $2.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 1.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Walleye Capital opened a new position in Cypress Semiconductor worth $17M.

  • Walleye Capital's largest Q4 2019 buy was Cypress Semiconductor: 727,918 shares worth $17M.
  • Walleye Capital added most to Acacia Communications Inc in Q4 2019, an estimated $8.45M increase.
  • Walleye Capital's biggest Q4 2019 reduction was Humana, cutting an estimated $2.77M.
  • Walleye Capital fully exited Cigna in Q4 2019, selling an estimated $2.57M.
  • Walleye Capital's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2019.
  • Walleye Capital opened 653 new positions and closed 777 in Q4 2019.
  • Walleye Capital's portfolio value fell 8.2% quarter-over-quarter to $1.54B.

Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.